Using Frovatriptan for Migraine Treatment
Author Information
Author(s): Peer Carsten Tfelt-Hansen
Primary Institution: Danish Headache Center, Glostrup Hospital, University of Copenhagen
Hypothesis
Is frovatriptan an effective treatment for migraine compared to other triptans?
Conclusion
Frovatriptan is not the first choice for moderate to severe headaches but can be a good alternative if taken early.
Supporting Evidence
- Frovatriptan had a similar efficacy to rizatriptan and almotriptan in two RCTs.
- The therapeutic gain for frovatriptan was 19%, compared to 27-36% for other triptans.
- Patients in the trials were instructed to treat migraines early, which may have influenced results.
Takeaway
Frovatriptan can help with migraines, but it's better to take it early, and it's not as effective as some other migraine medications.
Methodology
Two cross-over randomized controlled trials were conducted comparing frovatriptan with other triptans.
Potential Biases
The trials may have selection bias due to the exclusion of non-responders.
Limitations
Patients not responding to triptans were excluded, which may affect the generalizability of the results.
Participant Demographics
Migraine patients with moderate to severe headaches.
Statistical Information
Confidence Interval
95% CI 16–22%
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website